Diagnostic stewardship of fungal blood cultures in solid organ transplantation
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 09.11.2026. Verfasst von Julie M. Steinbrink und 11 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fungal blood cultures (fungal-isolator cultures) (FBCs) require extended incubation (4–6 wk) and substantial laboratory resources. However, their diagnostic yield is limited in solid organ transplant (SOT) recipients. Understanding the utilization patterns and yield of FBCs in SOT recipients is essential to inform diagnostic stewardship.
Methods
A retrospective, single-center study was conducted at Duke University Hospital (July 2021–January 2025) evaluating all FBCs collected from adult SOT recipients. Demographics, clinical indications, culture results, antifungal use, infectious diseases (ID) involvement, and outcomes were extracted from electronic medical records (EMRs).
Results
A total of 137 FBCs from 104 SOT recipients were analyzed. The cohort demonstrated high acuity, with a median hospitalization of 32 days and a 23% 6-month mortality. Heart transplant recipients accounted for the largest proportion (37%) of FBCs, as well as the largest proportion (46%) of inappropriate FBCs. Only 1 of 137 cultures (0.7%) yielded a fungal organism ( Histoplasma capsulatum ); 5 grew bacterial organisms. Two-thirds of cultures were collected, although patients were already receiving antifungals. ID was consulted in 91% of cases, but recommended FBC collection in only 42%. Sixty-nine percent of cultures were collected without a suspected fungal pathogen documented in the chart.
Conclusions
FBCs had an extremely low yield (0.7%) in SOT recipients with the sole positive isolate being a dimorphic fungus. Most cultures were collected without a targeted fungal pathogen and without ID recommendation, representing an opportunity for diagnostic stewardship interventions to reduce unnecessary utilization and associated laboratory burden and cost.
Zitieren
APA
Steinbrink, J. M., Johannesson, J., Whitmer, G., Lerman, J., Ellis, M., King, L., Reynolds, J., Hartwig, M., Schroder, J., Sudan, D., Alexander, B. D., & Seidelman, J. (2026). Diagnostic stewardship of fungal blood cultures in solid organ transplantation. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10953
Vancouver
Steinbrink JM, Johannesson J, Whitmer G, Lerman J, Ellis M, King L, et al. Diagnostic stewardship of fungal blood cultures in solid organ transplantation. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10953
BibTeX
@article{Steinbrink2026,
author = {Steinbrink, Julie M. and Johannesson, Jon and Whitmer, Grant and Lerman, Joseph and Ellis, Matthew and King, Lindsay and Reynolds, John and Hartwig, Matthew and Schroder, Jacob and Sudan, Debra and Alexander, Barbara D. and Seidelman, Jessica},
title = {Diagnostic stewardship of fungal blood cultures in solid organ transplantation},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10953}
}
EUVIMED